| Literature DB >> 31007684 |
Changbo Lu1, Xianglong Wu2, Hongzhe Ma1, Qingchuan Wang1,2, Yikai Wang1, Yan Luo1, Cong Li1,3, Hui Xu1.
Abstract
Motor capability recovery after ischemic stroke involves dynamic remodeling processes of neural connectomes in the nervous system. Various neuromodulatory strategies combining direct stimulating interventions with behavioral trainings for motor recovery after ischemic stroke have been developed. However, the effectiveness of these interventions varies widely due to unspecific activation or inhibition of undefined neuronal subtypes. Optogenetics is a functional and structural connection-based approach that can selectively activate or inhibit specific subtype neurons with a higher precision, and it has been widely applied to build up neuronal plasticities of the nervous system, which shows a great potential in restoring motor functions in stroke animal models. Here, we reviewed neurobiological mechanisms of enhanced brain plasticities underlying motor recovery through the optogenetic stimulation after ischemic stroke. Several brain sites and neural circuits that have been previously proven effective for motor function rehabilitation were identified, which would be helpful for a more schematic understanding of effective neuronal connectomes in the motor function recovery after ischemic stroke.Entities:
Mesh:
Year: 2019 PMID: 31007684 PMCID: PMC6441501 DOI: 10.1155/2019/5271573
Source DB: PubMed Journal: Neural Plast ISSN: 1687-5443 Impact factor: 3.599
Summary of targeted brain circuits or sites in motor recovery after ischemic stroke using the optogenetic stimulation.
| Experimental ischemic stroke model | Target method | Stimulation protocol | Stimulation time course | Recovery onset | Ref. |
|---|---|---|---|---|---|
| Mice, transient middle cerebral artery occlusion | Thy-1–ChR2–YFP line-18 transgenic mice which exhibited high levels of ChR2 in layer V of primary motor cortex pyramidal neurons | Activated pyramidal neurons in iM1 with 473 nm blue laser | Poststroke days 5-10, 10 Hz | Significant improvement from day 14 | [ |
| Mice, transient middle cerebral artery occlusion | Thy-1–ChR2–YFP line-18 transgenic mice | Activated neurons (mainly excitatory neurons) in cLCN with 473 nm blue laser | Poststroke days 5–14, 10 Hz | Significant improvement from day 14. | [ |
| Rat, middle cerebral artery occlusion | Injection of a Cre-recombinase-dependent ChR2 vector achieved the specific expression of ChR in corticospinal-projecting neurons | Activated corticospinal projecting neurons specifically expressing ChR2 with 473 nm blue LEDs | Poststroke days 3–14, 10 Hz | Significant improvement from day 21 | [ |
| Mice, ligations of distal branches of the middle cerebral artery | ChR2 transgenic mice (B6.Cg-Tg (Thy1-COP4/EYFP)18Gfng/J) and ChR2-YFP protein were selectively expressed in the excitatory glutamatergic neurons | Activated glutamatergic neuron in the striatum of the ChR2 transgenic mouse with 473 nm blue laser | Poststroke days 5–10, 10 Hz | Significant improvement from day 3 | [ |
| Mice, middle cerebral artery occlusion | Gad2-Arch-GFP transgenic mice and Arch-GFP were selectively expressed in GABAergic neurons expressed | Inhibited GABAergic neurons in striatum with 530 nm green laser | Poststroke days 5–14, 10 Hz | Significant improvement from day 14 | [ |
| Mice, middle cerebral artery occlusion | Injection of AAV2.CaMKII.hChR2(E123A) which drove ChR2 expression in thalamocortical projection neurons | Activated thalamocortical projecting neurons with 475 nm blue light | Poststroke days 3-42, 5 Hz | Significant improvement from day 14 | [ |
Figure 1Optogenetic targeting of neural circuits in the motor recovery after ischemic stroke in the mouse brain. The illustration depicts several targeting circuits or sites, (1) including stimulation of ischemic infarcted iM1 [31], (2) stimulation of efferent iM1-thalamus-spinal circuits [9], (3) stimulation of afferent thalamocortical circuits [46], (4) stimulation of multisynaptic projections of cLCN-thalamus-M1 [39], and (5) stimulation of striatum-SVZ projection for neurogenesis [54, 58]. Afferent and efferent circuits are distinguished as blue and red color, respectively.